A variant in FTO shows association with melanoma risk not due to BMI
- PMID: 23455637
- PMCID: PMC3640814
- DOI: 10.1038/ng.2571
A variant in FTO shows association with melanoma risk not due to BMI
Abstract
We report the results of an association study of melanoma that is based on the genome-wide imputation of the genotypes of 1,353 cases and 3,566 controls of European origin conducted by the GenoMEL consortium. This revealed an association between several SNPs in intron 8 of the FTO gene, including rs16953002, which replicated using 12,313 cases and 55,667 controls of European ancestry from Europe, the USA and Australia (combined P = 3.6 × 10(-12), per-allele odds ratio for allele A = 1.16). In addition to identifying a new melanoma-susceptibility locus, this is to our knowledge the first study to identify and replicate an association with SNPs in FTO not related to body mass index (BMI). These SNPs are not in intron 1 (the BMI-related region) and exhibit no association with BMI. This suggests FTO's function may be broader than the existing paradigm that FTO variants influence multiple traits only through their associations with BMI and obesity.
Figures


References
-
- Cannon-Albright LA, Bishop DT, Goldgar C, Skolnick MH. Genetic predisposition to cancer. Important Adv Oncol. 1991:39–55. - PubMed
-
- Naldi L, et al. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol. 2005;15:545–550. - PubMed
-
- Titus-Ernstoff L, et al. Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer. 2005;116:144–149. - PubMed
-
- Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol. 1995;141:923–933. - PubMed
-
- Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. II Phenotypic characteristics and other host-related factors. Am J Epidemiol. 1995;141:934–942. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA092824/CA/NCI NIH HHS/United States
- P30CA023108/CA/NCI NIH HHS/United States
- C8216/A6129/CRUK_/Cancer Research UK/United Kingdom
- WT084766/Z/08/Z/WT_/Wellcome Trust/United Kingdom
- CA87969/CA/NCI NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- A4994/CRUK_/Cancer Research UK/United Kingdom
- CA83115/CA/NCI NIH HHS/United States
- C37059/A11941/CRUK_/Cancer Research UK/United Kingdom
- ImNIH/Intramural NIH HHS/United States
- P30 CA016520/CA/NCI NIH HHS/United States
- R01 CA088363/CA/NCI NIH HHS/United States
- A10589/CRUK_/Cancer Research UK/United Kingdom
- CA055075/CA/NCI NIH HHS/United States
- R01 CA133996/CA/NCI NIH HHS/United States
- R01 CA083115/CA/NCI NIH HHS/United States
- CA100264/CA/NCI NIH HHS/United States
- R01 CA65558-02/CA/NCI NIH HHS/United States
- CA49449/CA/NCI NIH HHS/United States
- 076113/WT_/Wellcome Trust/United Kingdom
- CA88363/CA/NCI NIH HHS/United States
- R01 CA122838/CA/NCI NIH HHS/United States
- CA133996/CA/NCI NIH HHS/United States
- C588/A10589/CRUK_/Cancer Research UK/United Kingdom
- C588/A4994/CRUK_/Cancer Research UK/United Kingdom
- P50 CA093459/CA/NCI NIH HHS/United States
- 10589/CRUK_/Cancer Research UK/United Kingdom
- R01 CA100264/CA/NCI NIH HHS/United States
- 2P50CA093459/CA/NCI NIH HHS/United States
- CA122838/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources